BayerDE000BAY0017BAYNBAYN
Financials
Market Cap
$29.77B5Y beta
1.03EPS (TTM)
-$3.225Free Float
982.17MRevenue (TTM)
$51.31BEBITDA (TTM)
$19.38BFree Cashflow (TTM)
$2.53BPricing
Analyst Ratings
The price target is $37.46 and the stock is covered by 25 analysts.
Buy
6
Hold
17
Sell
2
Information
Bayer AG is a German-based life science company. The Company's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on seeds, improved plant traits, chemical and biological crop protection products, digital solutions and customer service for sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others.